Supplemental Table 5 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas | Synapse
Supplemental Table 5 from A Phase 0/I Pharmacokinetic and Pharmacodynamics and Safety and Tolerability Study of Letrozole in Combination with Standard Therapy in Recurrent High-Grade Gliomas
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
Supplemental Table 5: List of differentially expressed genes